Lemaitre Vascular Inc
Lemaitre Vascular Inc (LMAT) Covered Calls
As of September 25, 2026, LMAT has 10 covered call opportunities in the coming three months. Return ranges from 5.7 to 23.9% until expiration. Annualized return ranges from 21.0 to 102.4%. The nearest expiration is October 16, 2026. Maximum potential profit is $1,928.
Read more
Running LMAT covered calls helps you generate consistent income from Lemaitre Vascular Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Lemaitre Vascular Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best LMAT covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if LMAT stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling LMAT covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Lemaitre Vascular Inc covered call is worth writing.
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin.
In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
Income-focused investors, long-term LMAT holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling LMAT covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Lemaitre Vascular Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryMedical Instruments & Supplies
- SectorHealthcare
- IV percentile51.19% Neutral
- Market cap (M$)1,864
- 52 weeks high-30.92%
- 52 weeks low4.22%
- Analyst recommendationBuy
2.00 - Target price$107.00
30.74% above the current stock price - Dividend—
- Payout ratio31.77%
- Earnings date2026-11-05
- P/E29.04
- Future P/E25.65
- EPS (ttm)2.81
- EPS growth next 5 years11.16%
As of September 25, 2026
| 2026-12-18 | 85 | 100.00 | 23.73 | 0.10 | 4.90 | 1928.00 | 23.86 | 102.44 | -0.12 | +0.24 | 1 | 4.80 |
| 2026-10-16 | 22 | 85.00 | 5.17 | 0.40 | 0.80 | 458.00 | 5.67 | 94.02 | -0.49 | +0.22 | 41 | 0.40 |
| 2026-12-18 | 85 | 95.00 | 17.55 | 0.05 | 4.00 | 1423.00 | 17.61 | 75.61 | -0.06 | +0.24 | 2 | 3.95 |
| 2026-12-18 | 85 | 90.00 | 11.36 | 1.10 | 4.90 | 1028.00 | 12.72 | 54.62 | -1.36 | +0.33 | 1 | 3.80 |
| 2027-03-19 | 176 | 100.00 | 23.73 | 0.10 | 4.90 | 1928.00 | 23.86 | 49.47 | -0.12 | +0.24 | 2 | 4.80 |
| 2026-11-20 | 57 | 85.00 | 5.17 | 1.00 | 5.50 | 518.00 | 6.41 | 41.04 | -1.24 | +0.41 | 0 | 4.50 |
| 2026-12-18 | 85 | 85.00 | 5.17 | 3.20 | 5.70 | 738.00 | 9.13 | 39.21 | -3.96 | +0.45 | 48 | 2.50 |
| 2027-03-19 | 176 | 95.00 | 17.55 | 0.55 | 5.40 | 1473.00 | 18.23 | 37.80 | -0.68 | +0.30 | 3 | 4.85 |
| 2027-03-19 | 176 | 90.00 | 11.36 | 2.15 | 7.00 | 1133.00 | 14.02 | 29.07 | -2.66 | +0.39 | 6 | 4.85 |
| 2027-03-19 | 176 | 85.00 | 5.17 | 4.00 | 8.50 | 818.00 | 10.12 | 20.99 | -4.95 | +0.49 | 1 | 4.50 |
As of September 25, 2026
Sell covered calls with the data behind you
Find the best LMAT covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→